跳至主要内容
临床试验/NCT03967847
NCT03967847已完成3 期

Oral Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Rotator Cuff Repair

University Hospitals Cleveland Medical Center1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2019年2月11日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
44
试验地点
1
主要终点
Postoperative Visual Analog Scale Scores

研究概览

简要总结

  1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent to the standard of care pain protocol for postoperative pain control following arthroscopic rotator cuff repair.
  2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the standard of care pain protocol will reduce postoperative opioid consumption following arthroscopic rotator cuff repair.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Ketorolac

Experimental

干预措施: Ketorolac (Drug)

结局指标

主要结局

Postoperative Visual Analog Scale Scores

时间窗: participants were assessed at one single time point up to 8 weeks.

The Visual Analog Scale ranges from a minimum score of 0 to a maximum score of 100. A smaller score would be considered a better outcome.

次要结局

  • Number of Participants With Retear of Rotator Cuff Repair(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert J. Gillespie

Principal Investigator

University Hospitals Cleveland Medical Center

研究点 (1)

Loading locations...

相似试验